Front-line therapy for nonlocalized diffuse large B-cell lymphoma: what has been demonstrated and what is yet to be established

Author： Brusamolino Ercole   Maffioli Margherita   Bonfichi Maurizio   Vitolo Umberto  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.4, Iss.2, 2008-04, pp. : 199-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy

By                          

Experimental and Therapeutic Medicine, Vol. 6, Iss. 1, 2013-01 ,pp. : 109-114

Spandidos Publications

Access to resources Recommend Favorite

Primary diffuse large B-cell lymphoma of the dura without systemic recurrence four years after diagnosis and successful therapy

By Berget Ellen  

Acta Oncologica, Vol. 52, Iss. 5, 2013-06 ,pp. : 1047-1049

Informa Healthcare

Access to resources Recommend Favorite

Management of Diffuse Large B-Cell Lymphoma in Young Patients

By Pfreundschuh Michael  

American Journal of Cancer, Vol. 4, Iss. 6, 2005-01 ,pp. : 349-357

Adis International

Access to resources Recommend Favorite

Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma

By Avilés Agustin   Jesús Nambo M.   Neri Natividad   Talavera Alejandra   Castañeda Claudia   Murillo Edgar   Cleto Sergio   Huerta-Guzmán Judith  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 269-272

Humana Press, Inc

Access to resources Recommend Favorite

Subcutaneous diffuse large B-cell lymphoma with intraocular involvement

By Chi Ming   Bucher Nora   Gabrielian Anna   MacCumber Mathew W   Zdunek Teresita  

Future Oncology, Vol. 8, Iss. 6, 2012-06 ,pp. : 757-760

Future Medicine

Access to resources Recommend Favorite